Insider Cluster (2 insiders) ·Filed Jun 18, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $221K total
Actionable Insight • Neutral

The cluster is too small to convey a bearish signal. Monitor for larger insider moves or C-suite participation before drawing conclusions. The company's strong analyst consensus (86% bullish) and recent institutional accumulation suggest no near-term concern.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ARQT ▼ -7.40% at T+60d
NEUTRAL call ✗ call lost -7.40% · α vs SPY -9.30% · entry $26.21 → $24.27
Entry anchored
Jun 17, 03:59 PM ET
via exchange tick
T+1d
+1.72%
call +1.72% · α +2.03%
$26.66
settled 4mo ago
T+5d
+1.83%
call +1.83% · α +3.50%
$26.69
settled 3mo ago
T+20d
+5.84%
call +5.84% · α +5.30%
$27.74
settled 3mo ago
T+60d
-7.40%
call -7.40% · α -9.30%
$24.27
settled 18d ago

Price Chart

Loading chart...

Executive Summary

Two directors at Arcutis Biotherapeutics sold a combined $221K in open-market transactions over a 7-day window. The total value represents approximately 0.007% of the company's $3.2B market cap, making this a trivial cluster with no material signal for traders.

Key Financial Metrics

Direction
selling
Total Value
$221.0K
Insiders
2

Key Facts

  • Two directors (Welgus Howard G. and LIN SUE-JEAN) sold shares totaling $221K
  • Total sales represent ~0.007% of ARQT's $3.2B market cap
  • Welgus also exercised non-cash derivative transactions (822 shares at $0 and 822 shares at $6.52) alongside the sales
  • No C-suite executives participated in the cluster

Financial Impact

Insider sales of $221K, negligible relative to $3.2B market cap

insider ownership

Risk Factors

  • Insider selling could accelerate if stock price continues to rise, but current levels are routine

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARQT-1781743656282
17 reports for ARQT
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +14.74%Mar 2, 2026
Filters
Rows
Reports for ARQT — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.86 $26.38▲ +6.11%▲ +5.87%$25.16 (+1.21%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.08 $25.96▲ +3.51%▲ +4.04%$25.16 (+0.32%)
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.35 $25.38▲ +0.12%▲ +0.12%$25.16 (−0.75%)
Aug 11, 2026
7w ago
144
NEUTRAL ★ 3/10
$26.28 $23.38▼ −11.04%▼ −9.14%$25.16 (−4.26%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.43 $23.66▼ −10.48%▼ −11.08%$25.16 (−4.81%)
Aug 5, 2026
8w ago
Press Release
BULLISH ★ 7/10
$26.43 $23.66▼ −10.48%▼ −11.08%$25.16 (−4.81%)
Aug 3, 2026
8w ago
144
NEUTRAL ★ 2/10
$26.03 $23.75▼ −8.76%▼ −7.52%$25.16 (−3.34%)
Jun 29, 2026
13w ago
Press Release
BULLISH ★ 7/10
$26.22 $27.84▲ +6.18%▲ +7.21%$25.16 (−4.04%)
Jun 18, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.21 $27.74▲ +5.84%▲ +5.30%$25.16 (−4.01%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$23.23 $28.78▲ +23.89%▲ +20.27%$25.16 (+8.31%)
Showing 10 of 17

US Market Status

Market Closed — Opens Mon (64h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 18, 2026